130 related articles for article (PubMed ID: 10985670)
1. Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.
Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Schenk F; Franzke A; Atzpodien J; Buer J
Melanoma Res; 2000 Aug; 10(4):355-62. PubMed ID: 10985670
[TBL] [Abstract][Full Text] [Related]
2. Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines.
Johansson M; Takasaki A; Lenner L; Arstrand K; Kågedal B
Melanoma Res; 2002 Jun; 12(3):193-200. PubMed ID: 12140375
[TBL] [Abstract][Full Text] [Related]
3. RT-PCR detection of tyrosinase, gp100, MART1/Melan-A, and TRP-2 gene transcripts in peripheral blood of melanoma patients.
Samija M; Juretić A; Solarić M; Samija I; Bingulac-Popović J; Grahovac B; Stanec M; Oresić V
Croat Med J; 2001 Aug; 42(4):478-83. PubMed ID: 11471202
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
[TBL] [Abstract][Full Text] [Related]
6. Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma.
Probst-Kepper M; Schrader A; Buer J; Grosse J; Volkenandt M; Illiger HJ; Metzner B; Kadar J; Duensing S; Hertenstein B; Ganser A; Atzpodien J
Br J Haematol; 1997 Aug; 98(2):488-90. PubMed ID: 9266956
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating melanoma cells by RT-PCR amplification of three different melanocyte-specific mRNAs in a mouse model.
Tsukamoto K; Hirata S; Osada A; Kitamura R; Shimada S
Pigment Cell Res; 2000 Jun; 13(3):185-9. PubMed ID: 10885678
[TBL] [Abstract][Full Text] [Related]
8. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U
Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581
[TBL] [Abstract][Full Text] [Related]
9. MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression.
Strohal R; Mosser R; Kittler H; Wolff K; Jansen B; Brna C; Stingl G; Pehamberger H
Melanoma Res; 2001 Oct; 11(5):543-8. PubMed ID: 11595894
[TBL] [Abstract][Full Text] [Related]
10. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma.
Schittek B; Bodingbauer Y; Ellwanger U; Blaheta HJ; Garbe C
Br J Dermatol; 1999 Jul; 141(1):30-6. PubMed ID: 10417512
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma.
Brownbridge GG; Gold J; Edward M; MacKie RM
Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559
[TBL] [Abstract][Full Text] [Related]
12. RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.
Itakura E; Huang RR; Wen DR; Paul E; Wünsch PH; Cochran AJ
Mod Pathol; 2008 Mar; 21(3):326-33. PubMed ID: 18204435
[TBL] [Abstract][Full Text] [Related]
13. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
[TBL] [Abstract][Full Text] [Related]
14. Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma.
Schmidt H; Sørensen BS; von der Maase H; Bang C; Agger R; Hokland M; Nexo E
Melanoma Res; 2002 Dec; 12(6):585-92. PubMed ID: 12459648
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR.
de Vries TJ; Fourkour A; Punt CJ; van de Locht LT; Wobbes T; van den Bosch S; de Rooij MJ; Mensink EJ; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 May; 80(5-6):883-91. PubMed ID: 10360670
[TBL] [Abstract][Full Text] [Related]
16. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
19. Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients.
Murer K; Urosevic M; Willers J; Selvam P; Laine E; Burg G; Dummer R
Melanoma Res; 2004 Aug; 14(4):257-62. PubMed ID: 15305155
[TBL] [Abstract][Full Text] [Related]
20. Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction.
Schittek B; Blaheta HJ; Flörchinger G; Sauer B; Garbe C
Br J Dermatol; 1999 Jul; 141(1):37-43. PubMed ID: 10417513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
